IIROC, CSA say they will act if they see manipulative trading in social media frenzy - Medicine Hat NewsMedicine Hat News medicinehatnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicinehatnews.com Daily Mail and Mail on Sunday newspapers.
IIROC, CSA say they will act if they see manipulative trading in social media frenzy - Business News castanet.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from castanet.net Daily Mail and Mail on Sunday newspapers.
Vancouver man charged for allegedly running makeshift nightclub released on bail
A Vancouver man has been released on strict bail conditions after being charged with violating public health orders by allegedly hosting dozens of people at a makeshift nightclub in his downtown penthouse. Seventy-seven people were fined.
Social Sharing
Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments Entheon or the Company ), a biotechnology company focused on developing psychedelic medicines to treat addiction, provides an update on license amendments issued to its clinical research organization, The Centre for Human Drug Research (CHDR).
Entheon confirms that the CHDR, the Company s Netherlands-based partner clinical research organization, has received an amendment to its opioid license, enabling it to possess and conduct research with DMT. The opioid license amendment enables the CHDR to accommodate Entheon s upcoming clinical study, designed to evaluate the pharmacodynamics, pharmacokinetics and safety of a target-controlled IV infusion of DMT in humans. In addition, CHDR s partner pharmacy, LUMC, has received its import permit to receive DMT, for testing and formulation work, from Entheon s Canadian manufacturing partner, Psygen Labs Inc.